This week, 8 Health Care Equipment & Supplies stocks are improving their overall rating on Portfolio Grader. Each of these rates an “A” (“strong buy”) or “B” overall (“buy”).
Natus Medical Incorporated (BABY) improves from a B to a A rating this week. Natus Medical Incorporated is a medical device company that develops, manufactures, and markets screening products. For more information, get Portfolio Grader’s complete analysis of BABY stock.
Globus Medical, Inc. Class A (GMED) shows solid improvement this week. The company’s rating rises from a C to a B. Globus Medical, Inc. Class A focuses on the design, development, and commercialization of products that promote healing in patients with spine disorders. For more information, get Portfolio Grader’s complete analysis of GMED stock.
SurModics, Inc.’s (SRDX) ratings are looking better this week, moving up to a B from last week’s C. SurModics, Inc. offers drug delivery and surface modification technologies to the healthcare industry. For more information, get Portfolio Grader’s complete analysis of SRDX stock.
This week, AtriCure, Inc. (ATRC) pushes up from a C to a B rating. AtriCure, Inc. engages in developing, manufacturing, and selling cardiac surgical ablation systems designed to create precise lesions or scars in cardiac tissue in the United States and internationally. For more information, get Portfolio Grader’s complete analysis of ATRC stock.
AxoGen, Inc. (AXGN) is seeing ratings go up from a B last week to a A this week. The company also gets A’s in sales growth and earnings revisions. For more information, get Portfolio Grader’s complete analysis of AXGN stock.
The rating of Cerus Corporation (CERS) moves up this week, rising from a C to a B. Cerus Corporation is a biomedical products company engaged in the development and commercialization of the INTERCEPT Blood System. For more information, get Portfolio Grader’s complete analysis of CERS stock.
Chembio Diagnostics, Inc. (CEMI) boosts its rating from a C to a B this week. Chembio Diagnostics, Inc. develops, manufactures, and markets rapid diagnostic tests that detect infectious diseases. For more information, get Portfolio Grader’s complete analysis of CEMI stock.
This is a strong week for Pro-Dex, Inc. (PDEX). The company’s rating climbs to B from the previous week’s C. Pro-Dex, Inc. designs, develops and manufactures rotary drive systems for the medical device and dental industries, motion control software and hardware for industrial and scientific applications and fractional horsepower DC motors for aerospace, medical and military applications. The company also gets A’s in sales growth and earnings growth. For more information, get Portfolio Grader’s complete analysis of PDEX stock.
Louis Navellier’s proprietary Portfolio Grader stock ranking system assesses roughly 5,000 companies every week based on a number of fundamental and quantitative measures. Stocks are given a letter grade based on their results — with A being “strong buy,” and F being “strong sell.” Explore the tool here.
